LOGO
LOGO

Corporate News

Verastem Shares Rise 5% On Strong AVMAPKI Sales Update

By RTTNews Staff Writer   ✉  | Published:  | Google News Follow Us  | Join Us

Verastem, Inc. (VSTM) shares rose 4.60 percent, or $0.29, to $6.59 on Wednesday, after the company reported preliminary results for the fourth quarter.

Net product revenue was about $17.5 million for the fourth quarter of 2025 and full-year revenue of approximately $30.9 million for AVMAPKI FAKZYNJA CO-PACK. The company also highlighted a solid cash position that extends its runway into the first half of 2027.

The stock opened at $6.42, compared with a previous close of $6.30, and traded between $6.42 and $7.00 on the New York Stock Exchange. The last bid was $4.96 and the ask was $8.30. Volume reached about 2,734,477 shares, above the average volume of 2,006,367. Verastem's 52-week range is $4.01 to $11.25.

For comments and feedback contact: editorial@rttnews.com

Business News

Get Access to Premium Stock Alerts with RTT Biotech Investor.
Global Economics Weekly Update - Jun 01 - Jun 05, 2026

June 05, 2026 16:18 ET
A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.

RELATED NEWS
Latest Updates on COVID-19